PRJNA207719: Tissue specific transcriptome profiling
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
nkx3-1 | dr11_v1_chr8_-_50259448_50259448 | 0.16 | 8.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_25249193 Show fit | 1.15 |
ENSDART00000171851
|
si:ch211-226h8.11 |
|
chr22_+_25236657 Show fit | 1.12 |
ENSDART00000138012
|
zgc:172218 |
|
chr9_+_8396755 Show fit | 0.98 |
ENSDART00000043067
|
zgc:171776 |
|
chr11_-_30636163 Show fit | 0.94 |
ENSDART00000140516
|
zgc:153665 |
|
chr2_+_11031360 Show fit | 0.80 |
ENSDART00000180020
ENSDART00000145093 |
acyl-CoA thioesterase 11a |
|
chr1_-_5542565 Show fit | 0.78 |
ENSDART00000160791
ENSDART00000103754 |
fibronectin 1b |
|
chr22_-_11623063 Show fit | 0.76 |
ENSDART00000145653
|
glucagon a |
|
chr2_+_4208323 Show fit | 0.75 |
ENSDART00000167906
|
GATA binding protein 6 |
|
chr19_-_5699703 Show fit | 0.74 |
ENSDART00000082050
|
zgc:174904 |
|
chr2_+_1486822 Show fit | 0.74 |
ENSDART00000132500
|
complement component 8, alpha polypeptide |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.4 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.2 | 1.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 1.1 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.8 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.2 | 0.7 | GO:0006600 | creatine metabolic process(GO:0006600) creatine biosynthetic process(GO:0006601) |
0.1 | 0.7 | GO:0055014 | ventricular cardiac myofibril assembly(GO:0055005) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.7 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.6 | GO:0043011 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 1.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.8 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.2 | 0.7 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
0.0 | 0.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.7 | GO:0022626 | cytosolic large ribosomal subunit(GO:0022625) cytosolic ribosome(GO:0022626) |
0.0 | 0.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.5 | GO:0045095 | keratin filament(GO:0045095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 1.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 0.9 | GO:0031769 | glucagon receptor binding(GO:0031769) |
0.1 | 0.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.8 | GO:0001948 | glycoprotein binding(GO:0001948) proteoglycan binding(GO:0043394) |
0.0 | 0.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |